COVID-19 Forum, Information, Studies, Treatments

COVID-19 Coronavirus => Doctors on 99+% Effective Treatments for COVID-19, With World Renowned $20 Remedies => Topic started by: admin on December 19, 2020, 08:31:47 AM

Title: WHO Bulletin-Mass treatment with ivermectin underutilized public health strategy
Post by: admin on December 19, 2020, 08:31:47 AM
WHO Bulletin:

Mass treatment with ivermectin: an underutilized public health strategy

Rick Speare (1) & David Durrheim (1)

Ivermectin was a revolutionary drug in the 1980s, the forerunner of a new group of antiparasitic agents with activity against both parasitic nematodes and arthropods. Initially it was marketed for veterinary use by Merck & Co. Inc.; it was used largely for nematode control in cattle, horses, pigs and dogs and became the standard for control of the ectoparasitic disease, scabies. The injectable cattle formulation, Ivomec, became the world’s most profitable veterinary drug (1).

Merck recognized Ivermectin’s potential for human use, particularly in the control of filariasis and most notably onchocerciasis, the cause of river blindness in West Africa, in the early 1980s. In collaboration with WHO, nongovernmental organizations and affected national governments, the company initiated a drug donation programme for onchocerciasis control that subsequently became the global model for philanthropic partnerships between pharmaceutical companies and countries unable to afford the drug. Profits from the veterinary use of ivermectin supported this programme (1).

Merck’s patent on ivermectin expired in 1996, though it was extended for different periods in various countries. Thus, other companies’ ivermectin preparations are now commercially available. Bioavailability of drugs depends on formulation and manufacturing processes, so the results obtained with the ivermectin manufactured by Merck may not apply to the new products. It is thus encouraging to see clinical trials evaluating new formulations of this valuable drug.

more
https://web.archive.org/web/20180522201418/http://www.who.int/bulletin/volumes/82/8/editorial30804html/en/
Title: Re: WHO Bulletin-Mass treatment with ivermectin underutilized public health strategy
Post by: admin on December 19, 2020, 08:38:42 AM
Since Ivermectin is up to 100% effective (https://www.covid-19forum.org/index.php?topic=461.0), both as a prophylaxis as well as in early treatment, it would seem that if everyone in the U.S. (or even the world) was given a dose of Ivermectin (the way they were in 8 Peruvian States (https://www.covid-19forum.org/index.php?topic=622.0)), with a followup dose for any that were still sick, the COVID-19 pandemic would be finished practically overnight, with no experimental vaccine the long term side effects on the immune system of which will remain unknown for years (https://www.covid-19forum.org/index.php?topic=185.0).